<p><b>(A)</b> Vero cells were pretreated with L-TH (120 nM) for different exposure time before incubation with cisplatin (60μM/24h). L-TH protected the cells from cisplatin induced dose-dependent loss of viability and L-TH protected the cells from cisplatin-induced cell death in time-dependent effect. <b>(B)</b> The cells were pretreated with different doses of L-TH two hours before they were IRR with either 2 or 6 Gy dose levels. Cell viability was determined using MTT assay after 24h incubation. Data are expressed as mean (% of control) ± SEM of three independent experiments. (*) indicates significant difference versus CIS-treated or 2Gy-irradiated cells (*<i>P</i>< 0.05).</p
<p>(A) Representative pictures and schematic of 2D (<i>i</i>, <i>iii</i>) and 3D (<i>ii, iv</i>) cel...
<p>QBC939 and HepG2 cells were treated with cisplatin for 12 or 24 h, and then cell viability, apopt...
Summary: Testicular cancer is the most common cancer affecting men in reproductive age, and cisplati...
Abstract Evidence on the impact of chemotherapy on radiotherapy-induced second malignant neoplasms i...
The use of cisplatin as a potential radiosensitizer in nasopharyngeal carcinoma (NPC) has produced e...
<p>HK-2 cells were treated with increasing concentrations of cisplatin (6.25–100 μM). (A) HK-2 cell ...
<p>A: dose-response curve of viability (MTT assay) of SH-SY5Y cells treated with different concentra...
<p>(A) LNCaP cells were treated at the indicated doses for 24 hours and proliferation was assessed. ...
<p>(<b>A</b>) CNE2 and HONE1 stable cell lines were treated with 0 or 2.0 μg/ml cisplatin. The MTT a...
Cisplatin (cis-cuammmedichloroplatinum(II)) is a highly effective chemotherapeutic drug given either...
<p>Cisplatin increased the rate of apoptosis in HK-2 cells. However, FIR exposure reduced the propor...
The present study was designed to analyse the cytotoxic effect of cisplatin in vitro as a function o...
Supplementary figure 1. Effects of cisplatin on viability of NRK52E cells and HK-2 cells.NRK52E cell...
Combined treatment of HeLa cells with cisplatin and irradiation under aerobic conditions leads to no...
PURPOSE: Investigation of the in vitro cytotoxic effect of X-rays, either alone or combined with cis...
<p>(A) Representative pictures and schematic of 2D (<i>i</i>, <i>iii</i>) and 3D (<i>ii, iv</i>) cel...
<p>QBC939 and HepG2 cells were treated with cisplatin for 12 or 24 h, and then cell viability, apopt...
Summary: Testicular cancer is the most common cancer affecting men in reproductive age, and cisplati...
Abstract Evidence on the impact of chemotherapy on radiotherapy-induced second malignant neoplasms i...
The use of cisplatin as a potential radiosensitizer in nasopharyngeal carcinoma (NPC) has produced e...
<p>HK-2 cells were treated with increasing concentrations of cisplatin (6.25–100 μM). (A) HK-2 cell ...
<p>A: dose-response curve of viability (MTT assay) of SH-SY5Y cells treated with different concentra...
<p>(A) LNCaP cells were treated at the indicated doses for 24 hours and proliferation was assessed. ...
<p>(<b>A</b>) CNE2 and HONE1 stable cell lines were treated with 0 or 2.0 μg/ml cisplatin. The MTT a...
Cisplatin (cis-cuammmedichloroplatinum(II)) is a highly effective chemotherapeutic drug given either...
<p>Cisplatin increased the rate of apoptosis in HK-2 cells. However, FIR exposure reduced the propor...
The present study was designed to analyse the cytotoxic effect of cisplatin in vitro as a function o...
Supplementary figure 1. Effects of cisplatin on viability of NRK52E cells and HK-2 cells.NRK52E cell...
Combined treatment of HeLa cells with cisplatin and irradiation under aerobic conditions leads to no...
PURPOSE: Investigation of the in vitro cytotoxic effect of X-rays, either alone or combined with cis...
<p>(A) Representative pictures and schematic of 2D (<i>i</i>, <i>iii</i>) and 3D (<i>ii, iv</i>) cel...
<p>QBC939 and HepG2 cells were treated with cisplatin for 12 or 24 h, and then cell viability, apopt...
Summary: Testicular cancer is the most common cancer affecting men in reproductive age, and cisplati...